BBOT

BridgeBio Oncology
BBOT

Overview Fund Trends Analyst Outlook Journalist POV
11.15 USD
--0.25
2.19%
At close Updated Oct 17, 4:00 PM EDT
1 day
-2.19%
5 days
-8.31%
1 month
3.34%
3 months
4.21%
6 months
3.53%
Year to date
1.46%
1 year
7.63%
5 years
9.42%
10 years
9.42%
 

About: BridgeBio Oncology Therapeutics Inc, formerly BridgeBio Oncology Therapeutics is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes.

Healthcare Biotechnology
0
Funds holding %
of 7,496 funds
Explore Fund Trends
0
Analysts bullish %
of 4 analysts
See Analyst Outlook
–
Positive news %
of articles
Check Journalist POV
Price charts implemented using Lightweight Charts™